MIRA INFORM REPORT

 

 

Report Date :

05.03.2014

 

IDENTIFICATION DETAILS

 

Name :

TEVAPHARM INDIA PRIVATE LIMITED [w.e.f. 07.09.2011]

 

 

Formerly Known As :

RATIOPHARM INDIA PRIVATE LIMITED

 

 

Registered Office :

402, Omega, Hiranandani Garden, Powai, Mumbai-400076, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

01.12.2000

 

 

Com. Reg. No.:

11-129835

 

 

Capital Investment / Paid-up Capital :

Rs.1114.438 Millions

 

 

CIN No.:

[Company Identification No.]

U33111MH2000FTC129835

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMR10449F

 

 

PAN No.:

[Permanent Account No.]

AAECR7561F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in manufacturing of formulation and also providing contract testing, research services, business development, procurement and pharma co vigilance related support services.

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (52)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 11190000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established company having fine track record.

 

The rating reflects healthy financial risk profile supported by adequate liquidity position and decent profitability of the company.

 

Trade relations are reported as fair. Business is active. Payments terms are reported to be regular and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

The worst is over for India’s economy with gross domestic product likely to expand 5 %to 5.5 % this year and more than 6 % in 2015, according to Moody’s Analytics. Concerns over the rupee and current account deficit are under control, said the agency. Ratings firm Crisil has forecast 6 % growth for 2014/15 up from the estimated 4.8 % for 2013/14.  Total economic growth, infrastructure bottlenecks and lack of transparency and consistency in foreign direct investment policies seem to have taken a toll on India’s attractiveness as an investment destination, says an Ernst & Young survey.  Projects with FDI component fell 16.4 % across the globe in 2012 from the previous year.  The drop in India was steeper at 21 %. State run carrier Air India is doling out free tickets to its 24000 employees, even as it expects to incur a loss of Rs 39000 mn this financial year and has a debt of Rs 350000 mn. 550000 number of jobs generated across India in 2013, a fall of 0.4 % as compared to with a year earlier. The National  Capital Region has a one-fourth share in total jobs created, according to a study by industry lobby group Assochem, Banks, real estate, automobile and telecommunications sectors are showing a rise of job creation. $ 805 mn investments by venture capital firms in India during 2013, registering a drop of about 18 % over the previous year. The Information Technology and IT-Enabled  Services Industry retained its status as the favourable venture capital investors in 2013. Pakistan has temporarily banned gold imports for the second time in six months, as it tries to stem smuggling into India. India’s import duty on gold is 10 % and curbs on purchases have dried up legal imports into what used to be the world’s biggest bullion buyers. The World Gold Council puts the amount smuggled into India at upto 200 tonnes in 2013. The Reserve Bank of India has proposed that unclaimed bank deposits estimated to be about Rs 35000 mn be used for education and awareness among depositors.  According to the plan, deposits that have not been claimed for at least 10 years will be transferred to the scheme.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Pallavi

Designation :

Account Manger

Contact No.:

91-832-6685500

Date :

05.03.2014

 

 

LOCATIONS

 

Registered Office :

402, Omega, Hiranandani Garden, Powai, Mumbai-400076, Maharashtra, India

Tel. No.:

91-22-66412100/101

Fax No.:

91-22-25705991

E-Mail :

ramesh.sadani@teva.co.in

tevapharm.india@teva.co.in

ashwin.trinindad@teva.co.in

 

 

Factory :

Plot A-1, Phase 1-A Averna, Verna, Goa, India

 

 

DIRECTORS

 

AS ON 28.06.2013

 

Name :

Eyal Arieli

Designation :

Director

Address :

PO Box 101, Kfar Harif - 79830, Israel

Date of Birth/Age :

13.08.1961

Date of Appointment :

04.10.2011

Din No.:

03360084

 

 

Name :

Mr. Eran Katz

Designation :

Director

Address :

Apartment 45206, Rakefet 10, Hod Hasharon, Israel

Date of Birth/Age :

30.09.1964

Date of Appointment :

27.06.2012

Din No.:

03588218

 

 

Name :

Mr. Kapildev Sapra

Designation :

Director

Address :

M-34, Saket, New Delhi-110017, India

Date of Birth/Age :

05.08.1972

Date of Appointment :

27.06.2012

Din No.:

00130600

 

 

Name :

Puru Aggarwal

Designation :

Director

Address :

19/702, Eastend Apartment, Mayur Vihar, Phase 1 Extension, Delhi-110096, India

Date of Birth/Age :

03.01.1967

Date of Appointment :

28.06.2013

Din No.:

02519685

 

 

Name :

Mr. Ramachandra Ganapati Naik

Designation :

Director

Address :

Row House, 9, Eternity, Kanakia Spaces, Teen Hath Naik, Thane-400602, Maharashtra, India

Date of Birth/Age :

12.05.1954

Date of Appointment :

28.06.2013

Din No.:

00297009

 

 

KEY EXECUTIVES

 

Name :

Mr. Ramesh Ramchand Sadani

Designation :

Secretary

Address :

71-A, Collectors Colony, Mahul Road, Chembur, Mumbai-400071, Maharashtra, India

Date of Birth/Age :

24.07.1966

Date of Appointment :

29.03.2005

Pan No.:

AAKPS6202Q

 

 

Name :

Pallavi

Designation :

Account Manger

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.06.2013

 

Names of Shareholders

No. of Shares

% age

Ratiopharm GmbH, Germany

50000000

44.87

Teva Pharmaceutical Investment Singapore Pte Limited, Singapore

61443750

55.13

TOTAL

111443750

100.00

 

 

AS ON 28.06.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in manufacturing of formulation and also providing contract testing, research services, business development, procurement and pharma co vigilance related support services.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

  • State Bank of India
  • Deutsche Bank
  • Bank of Baroda

 

 

Facilities :

--

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

BSR and Company

Chartered Accountants

Address :

1st Floor, Lodha Excelus, Apollo Mills Compound, N.M Joshi Marg, Mahalaxmi, Mumbai-400011, Maharashtra, India

PAN No:

AAIFB0630K

 

 

Holding Company :

Teva Pharmaceutical Investments Singapore PTE Limited

 

 

Associates :

  • Teva Pharmaceutical and Chemical Industries India Private Limited [U24230DL2003FTC183289]
  • Ratiopharm GmbH, Germany
  • Teva UK Ltd, United Kingdom
  • Teva Operations Poland Spzoo, Poland
  • Teva Pharmacutical Europe B.V, Netherlands
  • Teva Pharmaceutical USA
  • Teva Canada Limited
  • Teva Pharma Produtos Farmaceuticos Lda
  • Teva Pharmaceutical Works PLC
  • Teva India Private Limited
  • Ratiopharm International GmbH

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

200000000

Equity Shares

Rs.10/- each

Rs.2000.000 Millions

150000000

Preferences Shares

Rs.10/- each

Rs.1500.000 Millions

 

 

 

 

 

TOTAL

 

Rs.3500.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

111443750

Equity Shares

Rs.10/- each

Rs.1114.438 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.12.2012

31.12.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

1114.438

500.000

(b) Reserves & Surplus

 

1683.809

369.498

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

2798.247

869.498

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

494.099

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

12.602

5.846

Total Non-current Liabilities (3)

 

12.602

499.945

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

273.608

402.110

(c) Other current liabilities

 

521.700

246.455

(d) Short-term provisions

 

123.775

0.534

Total Current Liabilities (4)

 

919.083

649.099

 

 

 

 

TOTAL

 

3729.932

2018.542

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1380.382

765.448

(ii) Intangible Assets

 

1.295

0.000

(iii) Capital work-in-progress

 

85.738

38.228

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

99.900

64.191

(d) Long-term Loan and Advances

 

50.597

43.050

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1617.912

910.917

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

328.735

715.112

(c) Trade receivables

 

362.588

258.311

(d) Cash and cash equivalents

 

1342.528

55.594

(e) Short-term loans and advances

 

75.604

77.019

(f) Other current assets

 

2.565

1.589

Total Current Assets

 

2112.020

1107.625

 

 

 

 

TOTAL

 

3729.932

2018.542

 

 

SOURCES OF FUNDS

 

 

 

31.12.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

500.000

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

255.959

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

755.959

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

428.137

TOTAL BORROWING

 

 

428.137

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

1184.096

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

807.994

Capital work-in-progress

 

 

39.045

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

38.399

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

209.778

 

Sundry Debtors

 

 

191.342

 

Cash & Bank Balances

 

 

36.348

 

Other Current Assets

 

 

2.793

 

Loans & Advances

 

 

73.989

Total Current Assets

 

 

514.250

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

94.037

 

Other Current Liabilities

 

 

108.555

 

Provisions

 

 

13.000

Total Current Liabilities

 

 

215.592

Net Current Assets

 

 

298.658

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

1184.096

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.12.2012

31.12.2011

31.12.2010

 

SALES

 

 

 

 

 

Income

 

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

3399.376

1472.452

817.542

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

2552.312

1161.346

479.577

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

847.064

311.106

337.965

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

8.696

11.140

6.328

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

838.368

299.966

331.637

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

169.979

149.039

128.889

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

668.389

150.927

202.748

 

 

 

 

 

Less

TAX                                                                  (H)

214.291

37.388

87.246

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

454.098

113.539

115.502

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

369.499

255.959

140.457

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

823.597

369.498

255.959

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

3340.097

1446.255

794.646

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

406.268

47.234

 

 

Packing materials

NA

5.570

1.293

 

 

Capital Goods

NA

56.591

62.985

 

 

Stores and spares

NA

24.567

4.947

 

TOTAL IMPORTS

NA

492.996

116.459

 

 

 

 

 

 

Earnings Per Share (Rs.)

4.07

--

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2012

31.12.2011

31.12.2010

PAT / Total Income

(%)

13.36

7.71

14.13

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

18.86

7.88

15.33

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.17

0.27

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.57

0.57

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.30

1.71

2.39

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

 

31.12.2011

31.12.2012

 

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

 

500.000

1114.438

Reserves & Surplus

 

369.498

1683.809

Net worth

 

869.498

2,798.247

 

 

 

 

long-term borrowings

 

494.099

0.000

Short term borrowings

 

0.000

0.000

Total borrowings

 

494.099

0.000

Debt/Equity ratio

 

0.568

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.12.2010

31.12.2011

31.12.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

817.542

1472.452

3399.376

 

 

80.107

130.865

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.12.2010

31.12.2011

31.12.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

817.542

1472.452

3399.376

Profit

115.502

113.539

454.098

 

14.13%

7.71%

13.36%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY

 

OPERATIONS:

 

The Company has achieved a total income of Rs. 3399.376 Millions in the current year compared to Rs. 1472.452 Millions in the previous year from export of pharma products and R and D Pharma and Technical Services, thus registering 130 % increase in sales growth over the previous year. For the year, the profit after tax was Rs. 454.098 Millions as against Rs. 113.539 Millions in the previous year. There were two fire incidents at its factory site at Verna, Goa as a result of which certain fixed assets were burnt/ damaged and the claims are in process by the insurance company. The Company has acquired industrial land on lease from the Gujarat Industrial Development Corporation (GIDC) at Sanand, Ahmedabad for its OTC project. During the year, an amount Rs. 646.725 Millions has been incurred on the said OTC project

 

 

Unsecured Loan

As on 31.03.2012

[Rs. in Millions]

As on 31.03.2011

[Rs. in Millions]

Long Term Borrowings

 

 

Loans and advances from related parties

0.000

494.099

 

 

 

TOTAL

0.000

494.099

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.90

UK Pound

1

Rs.103.25

Euro

1

Rs.85.14

 

 

INFORMATION DETAILS

 

Information Gathered by :

HNA

 

 

Report Prepared by :

KVT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

52

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.